Showing results (221-230 of 348) with videos related to
Sort By:
Pageof 35
Alcoholism, Clinical and Experimental Research|May 22, 2007
Acute ethanol administration rapidly increases phosphorylation of conventional protein kinase C in specific mammalian brain regions in vivoMary Beth Wilkie, Joyce Besheer, Stephen P Kelley, et al.The Journal of the Acoustical Society of America|September 22, 2025
Characterization and modeling source levels of commercial vessels in the Gulf of MexicoKatrina H Johnson, Vanessa M ZoBell, Lynne E W Hodge, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 1, 1997
Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUC1 gene and the murine T-cell costimulatory molecule B7J Akagi, J W Hodge, J P McLaughlin, et al.Cancer Immunology Research|August 6, 2014
Immune consequences of decreasing tumor vasculature with antiangiogenic tyrosine kinase inhibitors in combination with therapeutic vaccinesBenedetto Farsaci, Renee N Donahue, Michael A Coplin, et al.Journal of Contemporary Brachytherapy|January 30, 2014
Prostate-specific antigen bounce predicts for a favorable prognosis following brachytherapy: a meta-analysisMichael B Bernstein, Nitin Ohri, James W Hodge, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2013
Combination therapy with a second-generation androgen receptor antagonist and a metastasis vaccine improves survival in a spontaneous prostate cancer modelAndressa Ardiani, Benedetto Farsaci, Connie J Rogers, et al.Journal for Immunotherapy of Cancer|July 8, 2024
Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccinesJeffrey Schlom, Renee N Donahue, Claudia Palena, et al.Oral Oncology|July 27, 2019
Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancerSo-Jin Park, Wenda Ye, Roy Xiao, et al.Blood|August 6, 2005
Potential approach to immunotherapy of chronic lymphocytic leukemia (CLL): enhanced immunogenicity of CLL cells via infection with vectors encoding for multiple costimulatory moleculesClaudia Palena, Kenneth A Foon, Dennis Panicali, et al.Cancer Immunology Research|April 15, 2016
Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity CancersEllen C Moore, Harrison A Cash, Andria M Caruso, et al.Pageof 35